glp-1 and trump says U.S. to provide drugs for Medicare patients Dr Blitz: Medicare Deal for

How do you get approved for Semaglutide GLP-1

Today, Novo Nordisk estimates that just under 20 million people are treated with GLP-1 drugs.4 Given a well-stocked pipeline, a substantial global addressable population (the obese population alone is projected to exceed 1.2 billion by 20305), and in light of the very beneficial clinical profile of these drugs, it is plausible that over 100 million patients worldwide will be treated with GLP-1s in the near future

Plan sponsors are currently facing critical decisions regarding GLP-1 medications which require balancing costs, member health benefits, and evolving medication landscapes

It is the leading cause of liver transplant waitlist additions

doi: 10.1016/j.diabet.2019.10.001